March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Thrombin Increases Human Corneal Fibroblast Expression Of The Chemokines, CXCL1, CCL2, IL-6, IL-8, CXCL10 And CCL13
Author Affiliations & Notes
  • Sally S. Twining
    Biochemistry and Ophthalmology, Medical College of Wisconsin, Milwaukee, Wisconsin
  • Debra J. Warejcka
    Biochemistry and Ophthalmology, Medical College of Wisconsin, Milwaukee, Wisconsin
  • Footnotes
    Commercial Relationships  Sally S. Twining, None; Debra J. Warejcka, None
  • Footnotes
    Support  RO1-EY012731 and P30 EY001931
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 1088. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sally S. Twining, Debra J. Warejcka; Thrombin Increases Human Corneal Fibroblast Expression Of The Chemokines, CXCL1, CCL2, IL-6, IL-8, CXCL10 And CCL13. Invest. Ophthalmol. Vis. Sci. 2012;53(14):1088.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Proteins of the coagulation cascade are synthesized by corneal cells and result in the activation of prothrombin to thrombin after injury to the epithelial layer or the stroma. Thrombin increases proinflammatory chemokines and cytokines such as CXCL1, CCL2, IL-6 and IL-8 in many tissues but has not been studied in the corneal fibroblasts. The purpose of this study was to determine whether thrombin increases human corneal stromal fibroblast expression of these chemokines plus CXCL10, an antiangiogenic chemokine, and CCL13, a proinflammatory chemokine which have not been previously studied in the presence of thrombin.

Methods: : Stromal cells were isolated from three pairs of human donor corneas and were expanded in culture and treated with 1 ng/ml fibroblast growth factor (FGF). After seven days, cells were treated with 0, 0.1 or 1 unit/ml α-thrombin for 1 hour (for mRNA) or 12 hours (for ELISA). RNA was purified and primers for CXCL1, CCL2, IL-6, IL-8, CXCL10, CCL13 and GAPDH were used in real time PCR. Twelve hour supernatants were assayed by ELISA for protein levels of the various chemokines.

Results: : One unit/ml thrombin increased mRNA expression in stromal fibroblasts for IL-6 (15 fold) , IL-8 (7 fold), CXCL1 (6 fold), and CCL2 (7 fold) over untreated cells Expression of message for CXCL10 was increased (10 fold) and CCL13 mRNA increased only 2 fold when cells were treated with 1 unit/ml thrombin. Treatment of cells with thrombin increased protein expression of IL-6 (from 5 to 520 pg/ml), IL-8 (from 7 to 30 pg.ml), CXCL1 (from 112 to 1904 pg/ml), CCL2 (from 1586 to 9888 pg/ml), CXCL10 (from 3 to 17 pg/ml) and CCL13 (from 0 to 14 pg/ml).

Conclusions: : As expected, thrombin treatment of corneal fibroblasts increased expression of proinflammatory chemokines such as CXCL1, CCL2, IL-6 and IL-8. Expression of CXCL10 and CCL13 mRNA and proteins were also increased by thrombin treatment of stromal fibroblasts. Regulation of CXCL10 and CCL13 by thrombin has not been previously described. These results suggest that thrombin generated in response to corneal injury can regulate the immune response.

Keywords: cornea: stroma and keratocytes • wound healing • cornea: basic science 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×